Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
1.070
+0.070 (7.00%)
At close: Jan 22, 2026, 4:00 PM EST
1.060
-0.010 (-0.93%)
After-hours: Jan 22, 2026, 7:12 PM EST
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $7.81 million as of January 22, 2026. Its market cap has decreased by -24.91% in one year.
Market Cap
7.81M
Enterprise Value
-11.69M
1-Year Change
-24.91%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $7.81M, a decrease of -96.96%. That is a compound annual growth rate of -33.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 7.30M | 1.39% |
| Dec 31, 2025 | 7.20M | -15.29% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
| Aug 22, 2017 | 257.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |